News

Around the world, more bacterial infections are growing resistant to standard antibiotics, making them harder to treat. Antimicrobial resistance is especially dangerous for critically ill newborns, infants and young children,

Penta ID Network members and Scientific Steering Committee chairs Ali Judd and Pablo Rojo have co-authored a commentary in The Lancet Child & Adolescent Health calling for urgent action to…

For most families, leaving the hospital is a moment of relief. It signals recovery, hope, and a return to normal life. But for children living with HIV who have been…

In recent years, we have seen a resurgence of vaccine-preventable diseases, reversing progress that could have been sustained through effective immunisation programmes. Penta strongly supports childhood vaccination as one of…

This year, the Penta Young Reporters attended the 18th International Workshop on Pediatrics & HIV and the AIDS 2026 Conference in Rio de Janeiro, Brazil. It was fantastic to see…

Following closely on the publication of the PregInPoxVac children’s protocol, the PregInPoxVac maternal protocol paper has now been published in BMJ Open.

New results from the D3 (PENTA-21) trial, sponsored by Fondazione Penta ETS, add to the evidence that dolutegravir-based treatment remains a strong option for children living with HIV,

Every year, millions of children are admitted to hospitals with severe pneumonia, mostly in resource-limited settings. Until now, standard international guidelines have required children to stay in the hospital for…

Fondazione Penta ETS and the Medicines Patent Pool (MPP) have signed a Memorandum of Understanding (MoU), formalising a strategic collaboration to support the development and equitable access of priority health…

A protocol paper describing part of the PregInPoxVac study has been published in Vaccine. The paper outlines the design of a phase 3 trial evaluating the safety and immunogenicity of…

We’re pleased to share that a large delegation of Penta experts is heading to Rio de Janeiro, Brazil at the end of the month, taking part in three major events…

Uganda continues to face a high HIV burden among children and adolescents, with an estimated 71,000 young people aged under 15 years living with HIV and 3,100 AIDS-related deaths in…

Fondazione Penta is pleased to be part of a new international clinical development programme led by Enanta Pharmaceuticals, a clinical-stage biotechnology company, to advance zelicapavir, a new oral antiviral in…

About the author My name is José Sumbana, a young African investigator and Postdoctoral Fellow with a background in Microbiology, Biotechnology, and Life Sciences.

Every winter, hospitals around the world fill with infants struggling to breathe because of respiratory syncytial virus (RSV). Estimates show that RSV infects nearly every child by the time they…

We are pleased to share that Penta’s 2025 Annual Report is now available on our website. For more than thirty years, Penta has worked to ensure that pregnant people,

Looking ahead, Penta is expanding its research horizon by strengthening the integration between basic science, translational research and clinical trials. Over recent years, the Foundation has worked with partners to…

Neonatal sepsis remains a leading cause of newborn mortality across Africa, requiring not only effective antibiotic treatments but also research that is grounded in the needs and realities of families.